A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
Status:
Suspended
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the maximally tolerated dose (MTD) of
HGS1036 when used in combination with the standard chemotherapeutic regimens paclitaxel plus
carboplatin, cisplatin plus etoposide, or docetaxel.